Conway Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Conway Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-425	Closed	-$222K	–	44
2023 Q2	$222K	Hold	425	–	–	0.16%	44
2023 Q1	$245K	Hold	425	–	–	0.2%	41
2022 Q4	$234K	Hold	425	–	–	0.24%	41
2022 Q3	$216K	Hold	425	–	–	0.19%	45
2022 Q2	$231K	Hold	425	–	–	0.21%	43
2022 Q1	$251K	Hold	425	–	–	0.16%	51
2021 Q4	$284K	Sell	425 -25	-6%	-$15.6K	0.17%	48
2021 Q3	$257K	Sell	450 -25	-5%	-$13.7K	0.17%	57
2021 Q2	$240K	Hold	475	–	–	0.16%	64
2021 Q1	$217K	Hold	475	–	–	0.16%	67
2020 Q4	$221K	Buy	+475	New	+$223K	0.16%	65

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Conway Capital Management's TMO Position: Q3 2023 in Review

Conway Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 425 shares — an estimated $222K sold.

Conway Capital Management first reported a position in TMO in Q4 2020 and held it in 11 quarters. The position peaked at $284K in Q4 2021. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Conway Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
Conway Capital Management sold 425 Thermo Fisher Scientific shares in Q3 2023, an estimated $222K.
Conway Capital Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 11 quarters.
Conway Capital Management's Thermo Fisher Scientific position peaked at $284K in Q4 2021.
2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Conway Capital Management's 13F filing for Q3 2023, filed 3 Dec 2024.